Investing

Aldeyra Therapeutics : ALDX

ALDX

Stock Data

$5.19

$0.03 (0.57%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Aldeyra Therapeutics Inc is a pioneering biotech firm focused on creating innovative treatments for immune-mediated diseases. Its flagship product, reproxalap, aims to alleviate dry eye diseases and is currently in advanced testing stages. The company is also exploring treatments for COVID-19, asthma, psoriasis, and alcohol intoxication through ADX-629, and tackling rare retinal diseases with ADX-2191. Founded in 2004 and based in Lexington, Massachusetts, Aldeyra is committed to addressing unmet medical needs in inflammation and vision loss.

All Aldeyra Therapeutics Articles

2 Articles

Trey Thoelcke | Apr 21, 2024 at 8:45 AM EDT

Buffett Grabs More of This Stock, Plus Other Notable Insider Buying

Warren Buffett boosted his stake in this tracking stock again, plus notable insider buying in the past week at biotechs,…

Trey Thoelcke | Apr 7, 2024 at 8:55 AM EDT

Insiders Scoop Up Shares of These 5 Stocks for the Second Quarter

A renowned billionaire investor, a French energy giant, and other insiders were scooping up shares of these five stocks as…